NCT06941688 2025-04-24Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell LymphomaSeoul National University HospitalPhase 2 Terminated17 enrolled
NCT03947255 2023-10-13A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell LymphomaSeagen Inc.Phase 2 Terminated12 enrolled 17 charts
NCT02314247 2023-01-26Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell LymphomaKaryopharm Therapeutics IncPhase 2 Terminated16 enrolled 16 charts
NCT00632827 2020-04-27Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)University of California, San FranciscoPhase 2 Terminated21 enrolled 13 charts
NCT01419795 2017-07-27Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Terminated3 enrolled 10 charts
NCT00810576 2012-08-07Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 3 charts
NCT00441025 2009-06-25The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCLMahidol UniversityPhase 2 Terminated4 enrolled